The association between the mode of death and depression in patients with stable coronary artery disease (CAD) is far from clear. We investigated the association between depressive symptoms ACCEPTED MANUSCRIPT A C C E P T E D M A N U S C R I P T 2 and the mode of death including all-cause mortality, non-cardiac death, sudden cardiac death (SCD) and non-SCD in stable CAD patients. Patients with angiographically documented CAD (n=1,928) underwent a clinical examination including screening for depression symptoms with the Depression Scale (DEPS) and extensive risk profiling at the baseline. The patients were divided into quartiles based on their DEPS score. The patients entered the follow-up (median 6.3 years) during which 49 SCDs (2.5%) and 48 non-SCDs (2.5%) occurred. The incidence of SCD was 1.1% (5 events), 2.0% (9 events), 2.6% (14 events) and 4.4% (21 events) from the lowest to the highest quartile of DEPS. The patients in the highest quartile of DEPS had a 4.0-fold elevated univariate risk (95 % CI: 1.5-10.5; p=0.006), and after adjustment for traditional risk factors, a 3.2-fold elevated multivariate risk (95 % CI: 1.2-8.9, p=0.025) for SCD compared to patients in the lowest quartile. DEPS was not associated with non-SCD or non-cardiac deaths. Depressive for SCD in patients with stable CAD. The patients were recruited from a consecutive series of patients who had undergone coronary angiography 3-6 months earlier and had > 3 months from any possible previous acute coronary syndrome before enrollment. Significant CAD was confirmed by coronary angiography (stenosis > 50%) and type 2 diabetes (DM2) according to the WHO criteria. Detailed inclusion and exclusion criteria have been described elsewhere in detail 3 .
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3 of about 4% in the general population 1 . There is convincing evidence that depression is an independent risk factor for a poor prognosis among cardiac patients and the elderly population 1, 2 .
In particular, depression may be associated with cardiac death and non-fatal cardiac events after an acute coronary syndrome 1 . However, the association between depression and a specific form of cardiac death, i.e. sudden cardiac death (SCD) vs. non-SCD, is not known among CAD patients. We hypothesized that depression symptoms may be associated with cardiac mortality independently of traditional risk markers including left ventricular function and life style factors and tested this hypothesis in a consecutive series of stable CAD patients attending Oulu
University Hospital at 2007-2014. We analyzed the association between depressive symptoms and all-cause mortality, non-cardiac death, non-SCD and SCD adjusted with appropriate risk markers.
Methods
The study population comprised 1,928 patients from the ARTEMIS (Innovation to Reduce Cardiovascular Complications of Diabetes at the Intersection, ClinicalTrials.gov identifier:
NCT01426685) study database (n=1,946, none lost cases during follow-up) collected in the Division of Cardiology of the Oulu University Hospital (Oulu, Finland). The ARTEMIS study aims to assess several traditional and novel cardiovascular risk markers as determinants of risk for SCD in patients with stable CAD. The patients were recruited from a consecutive series of patients who had undergone coronary angiography 3-6 months earlier and had > 3 months from any possible previous acute coronary syndrome before enrollment. Significant CAD was confirmed by coronary angiography (stenosis > 50%) and type 2 diabetes (DM2) according to the WHO criteria. Detailed inclusion and exclusion criteria have been described elsewhere in detail 3 .
Shortly, patients with age <18 years or >85 years, New York Heart Association class IV, a ACCEPTED MANUSCRIPT
permanent pacemaker or implantable cardioverter defibrillator, planned implantable cardioverter defibrillator implantation, or end-stage renal failure needing dialysis were excluded from this study, as well as patients who had a life expectancy of <1 year due to the severe other disease.
The study was performed according to the Declaration of Helsinki, and the local committee of research ethics of the Northern Ostrobothnia Hospital District approved the protocol and all the subjects provided written informed consent.
The patients filled in a self-rating Depression Scale (DEPS) 4 during the enrolment visit.
DEPS has been developed and validated in primary care patients. It is known that DEPS improves the recognition of depression and is also suitable for screening depression in the general population and for identifying high-risk groups 5 . The DEPS questionnaire contains ten items and each item is scored from 0 to 3 in increasing order of severity. A sum of DEPS score was calculated and the patients were divided into quartiles based on the score obtained (<2, 2-4, 5-7, ≥8). In earlier studies, the cut-off point for depression has been ≥ 8 points showing the sensitivity for depression 74-95 % with a specificity for non-depression of 85-74 % 5, 6 . The association between end-points and total DEPS score was calculated and the analyses were also performed for the individual items in the DEPS. The characteristics of patients according to DEPS score quartiles are shown in table 1 with the specific answers in DEPS described in table 2.
The patients filled in a health questionnaire containing a answer about the frequency of habitual leisure time physical activity (LTPA), smoking status and alcohol consumption during the enrolment visit. Four LTPA groups were formed by modifying the scale originally developed by Saltin and Grimby 7 : 1) Inactive; 2) Irregularly active; 3) Active, moderate-intensity LTPA regularly two to three times weekly; 4) Highly active, moderate-or high-intensity LTPA more than three times weekly 8 . The questionnaire has demonstrated good validity 9 and has been shown to be related to both cardiovascular risk factors 9,10 and outcomes 8 .
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A N U S C R I P T Deaths were defined as SCD, non-SCD and non-cardiac deaths. In addition, resuscitations from cardiac arrest were registered and combined with deaths, SCDs and cardiac deaths in statistical analyses, the aborted SCD being the primary event if patient died during the follow-up.
The primary endpoint of this study was SCD including resuscitations from cardiac arrest. The follow-up information was collected from the national death registries, from patients by mailed inquiry, telephone calls to the closest relatives of the deceased victims, and from the electronic patient records. SCD was defined as unexpected, witnessed death occurring within one hour after the onset of symptoms or unwitnessed death within 24 hours when the patient was last seen alive.
The cause of death was defined by an endpoint committee (MJJ, HVH) based on the death certificates, interviews with the closest relatives of victims and the autopsy reports. A medicolegal autopsy is mandatory in Finland according to the law and thus autopsy data was available in most cases.
In the Artemis study, we expected 5% and 2% incidence of SCD in the patients with and without type 2 diabetes during 5-year follow-up, respectively. With statistical power of 80% and 
Results
All cause-mortality was 10.5 % (202 events) during the median follow-up of 6.3 years (min -max: 2.2 -9.0 years in survivors). The incidence of cardiac deaths was 5.0 % (97 events) including 2.5 % SCDs (49 events) and 2.5 % non-SCDs (48 events). The incidence of noncardiac deaths was 5.4 % (105 events). All cause-mortality, cardiac deaths and SCDs included 8
aborted SCDs of whom, 2 suffered SCD and 2 had a non-SCD, whereas the other four remained alive during the follow-up.
The characteristics of patients in different DEPS quartiles are shown in 
multivariate risks, respectively). Finally, the changes in medication during follow-up were not associated with the severity of depression or the occurrence of SCD.
Discussion
The main finding of this study is that depressive symptoms are associated with the increase risk for SCD, but not for non-SCD or non-cardiac death, in patients with stable CAD in the current medical and revascularization era. This finding remained unchanged even after adjustment for traditional clinical risk markers including left ventricular function, psychotropic medication with or without known propensity for QT-prolongation and life style risk factors. The present results emphasize the importance of screening for depression in patients with stable CAD
and indicate that additional interventions should be undertaken to alleviate the depressive symptoms among these patients.
The association between depression, non-SCD and SCD has been investigated in four earlier studies. Irvine et al. found that depressive symptoms were associated with SCD in myocardial infarction patients but the association was not significant after adjustment for somatic symptoms such as subjective fatigue 12 . The data were collected two decades ago and left ventricular ejection fraction was not used as a covariate. In the three other studies, clinical depression or depressive symptoms have been shown to associated with SDCs in a cohort of elderly men and woman 2 , in a population based case-control study 13 and in a large cohort of women without coronary heart disease at baseline 14 . In all these studies, depressive symptoms remained as an independent risk factor for SCD after adjustment with traditional risk markers.
It is well known that the risk of SCD rises dramatically in conjunction with the number of coronary heart diseases risk factors. Major advances have been made in rapid revascularization during and after myocardial infarction in the last decade, and optimization of medical therapy
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A N U S C R I P T 9 among CAD patients has improved the prognosis of patients with CAD 15 . Therefore, there is a lack of knowledge concerning the association between depressive symptoms and the mode of death in the current treatment era in patients with a known CAD. The present findings could help to target health care resources more effectively to selected patients groups among CAD patients in order to prevent SCDs. The most powerful predictor for SCD was the answer "Felt that everything was an effort" revealing 3.5 fold risk for SCD in multivariate analysis. In the earlier validation study, the same answer has been the best item for recognizing depression, suggests reduction of energy, which is one of the main symptoms of depression according to the ICD-10 6 .
A lack of physical activity was the most powerful predictor of SCDs of the traditional covariates when analyzed without inclusion of the DEPS scale. The most passive group had a 2.9
fold increased risk for SCDs compared with the active group who performed moderate-intensity exercise regularly two to three times weekly. In addition, the most active group, performing moderate-or high-intensity exercise more than three times weekly, tended to have increased risk
for SCDs compared with the active group (moderate-intensity LTPA regularly two to three times weekly). Recently, a reverse J-shaped association has been documented between vigorous physical activity and cardiovascular mortality 16 . Both inactive and daily active patients displayed increased hazards of mortality compared to the reference group, in this trial, patients who were active two to four times per week 16 . Furthermore, it is rather well documented that exercise increases the risk of ventricular arrhythmias and sudden cardiac death during or after exertion, particularly in adults with heart disease; our results support these published reports 17, 18 .
Based on the present study, we can only speculate about the physiological mechanisms linking depression and SCDs. First, some psychotropic medication with known propensity for QT-prolongation have been reported to increase vulnerability to cardiac arrhythmic events, particularly in women 14 . However, removal of patients being administered psychotropic
A N U S C R I P T 10 medication without or with known propensity for QT-prolongation did not change the main results and therefore psychotropic medication does not seem to explain the association between depression symptoms and SCDs in the present study. Altered autonomic regulation is one potential mechanism leading to an increased prevalence on SCDs among depressive CAD patients. Augmented sympathetic activity and/or attenuated cardiac vagal activity have been
shown to be associated with cardiac events among large CAD patient populations [19] [20] [21] .
Furthermore, previous studies have observed abnormalities in autonomic regulation as documented by the heart rate variability method in CAD patients with depression 22 .
Unfortunately, convincing mechanisms linking SCDs and depression symptoms remain to be revealed. The triggering mechanism may not be one single physiological regulatory system but rather complex cascades of various harmful environmental (stress, eating habits, heat, cold etc.) and physiological factors.
This study did not include a clinical depression diagnosis. The DEPS scale has been validated only for screening purposes of depression in primary care patients; it identifies a depressed mood, but not the severity of depression 4 . Therefore, we are not able to make a statement about the possible association between the severity of clinical depression and cardiac events in CAD patients, despite the clear linear association between the depression symptoms and increased risk for SCD emerging from our data. Secondly, a large patient population with more clinical endpoints would be needed to confirm the link between the severity of depression symptoms/clinical depression and cardiac events. However, the sensitivity of DEPS scale for severe depression is rather high (84%) as is its specificity for symptom-free patients (93%) which highlights the validity of the found association between depression and SCDs 5 .
A N U S C R I P T 11 CAD patients suffering depression have an increased risk for SCD in the current medical care era. More attention should be paid to the evaluation and treatment of CAD patients with depression.
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